secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2022-10-14T23:59:59+00:00
Accession:  0001104659-22-108877
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx warned by Nasdaq: MVLS below $35M, faces potential delisting
------------------------------------------------------------------

- Received Nasdaq notice on Oct 11, 2022; MVLS below $35M minimum for 30 consecutive business days.
- No immediate effect on listing; common stock continues trading on Nasdaq Capital Market under symbol ELOX.
- 180-day compliance period until April 10, 2023 to regain compliance by closing MVLS at $35M+ for 10 consecutive days.
- If compliance not regained, Nasdaq will provide delisting notification; Company may appeal to hearings panel.
- Company intends to monitor MVLS and evaluate options but cannot assure regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922108877/0001104659-22-108877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922108877/tm2228182d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-108877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer